In this latest episode of Med Tech Talks, Robert Klupacs is joined by Brendon Gardner, CEO of The Royal Victorian Eye and Ear Hospital (Eye and Ear) in Melbourne. The Royal Victorian Eye and Ear Hospital is Australia’s only specialist eye, ear, nose and throat hospital and has been operating since 1863. The Eye and Ear sees over 250,000 patients a year and offers over 110 different outpatient clinics for the diagnosis, monitoring and treatment of vision and hearing loss. The hospital also has...
In this episode of Med Tech Talks, Robert Klupacs is joined by Dr Alastair Hick, Chief Commercialisation Officer at Monash University. With a PhD in Chemical Ecology and an MBA from the Judge Business School at the University of Cambridge, Alastair has a wealth of experience both in Australian and overseas markets and brings an ecosystem approach to commercialisation and innovation. At Monash University, Alastair has been responsible has developed a successful IP commercialisation program and...
In this episode of Med Tech Talks, Robert Klupacs is joined by Scott Kirkland, CEO and Managing Director of EMVision Medical Devices. EMVision (ASX:EMV) is an ASX listed, Australian med tech company focused on developing portable brain imaging devices using electromagnetic (EM) technology. It was spun out of University of Queensland in 2017 and had its IPO in late-2018. EMVision’s primary product is a portable scanner designed to quickly and non-invasively detect and monitor neuro...
In this episode of Med Tech Talks, Robert Klupacs is joined by Justin Zenanko, co-founder, CEO and president of SynerFuse™, a medical device company based in the United States developing an innovative solution to reduce chronic back pain and improve patient quality of life. Justin and his team have patented the SynerFuse e-TLIF™ procedure which aims to make traditional spine implant surgery more successful and cost effective by combining neuromodulation at the time surgeons are perform...
In this episode of Med Tech Talks, Robert Klupacs is joined by Dr Amir Zalcenstein, Managing Director of SYNthesis BioVentures. SYNthesis BioVentures is a registered early-stage venture Capital Limited partnerships fund, focused on early-stage therapeutics investing in projects from discovery through preclinical proof of concept and IND enabling studies. Amir and the team are investing in small molecule therapeutics, biologics and cell and gene therapies for conditions with significant ...
In this episode of Med Tech Talks, Robert Klupacs is joined by Dr Anne-Laure Puaux, inaugural CEO of WEHI Ventures and Head of Business Development at WEHI. WEHI Ventures manages 66ten, a first of its kind pre-seed and seed strategic investment fund of $66 million, dedicated to ideas developed by or in collaboration with, WEHI. With a grand vision of investing $66 million over 10 years in groundbreaking medical innovations, 66ten is the largest internal pre-seed and seed fund created by an Au...
In this episode of Med Tech Talks, Robert Klupacs is joined by Dr Megan Baldwin, Founder, Chief Innovation Officer and Executive Director of Opthea Limited. Opthea limited is a global biopharmaceutical company aspiring to become the leader of therapeutic innovation in retinal diseases. They have a world class team of ophthalmology experts working to develop breakthrough therapies for those who suffer from retinal disease. Megan has over 20 years of experience focusing on angiogen...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Bronwyn Le Grice, CEO and Managing Director of ANDHealth. Bronwyn has over 20 years executive experience in health technology commercialisation, venture capital, capital raising and industry advocacy. In 2017, she founded ANDHealth – which is now one of Australia’s leading health technology commercialisation organisations. It’s flagship ANDHealth+ program has a successful track record in taking businesses to sc...
In this episode of Med Tech Talks, Robert Klupacs is joined by Alon Greenspan, Managing Partner at Mind Ventures. Mind Ventures is touted as the world’s first mental health-focused for-profit venture fund. Seeded by the Black Dog Institute, Mind Ventures invests in scalable, evidence-based solutions across the mental health spectrum, from illness to well-being. Alon has a wealth of international global tech M&A and venture capital experience, having previously worked at Jelix Ventures, He...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Stephen Tomisich, Co-founder and CEO of Trajan Scientific and Medical. Based in Melbourne, Trajan develops and manufactures analytical science instruments, devices and solutions for health care, as well as for food and environment analysis – the only company of its kind listed on the ASX. Stephen has a strong acquisition strategy, having grown Trajan from a kitchen table concept in 2011 to a global collabo...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Chris Smith, a partner at Brandon Capital - Australasia's leading life science venture capital firm. Chris has extensive experience in the global biotech industry. With a PhD in immunology and an MBA specialising in innovation and entrepreneurship from the University of Cambridge; he has also previously been a business development manager with CSL; and is currently a Director of Aravax, Denteric, Ena Respiratory, MycRx, Q...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Professor Steve Wesselingh, CEO of the National Health and Medical Research Council (NHMRC). An infectious disease physician and researcher in HIV vaccine development and the impact of the microbiome on human health, Steve has a wealth of medical experience, clinical leadership, and national and international success. The NHMRC is Australia's lead agency, driving innovative health and medical research to improve the h...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Dean Freestone, Co-Founder of Seer Medical. A modern Australian innovation success story, Seer Medical was founded in 2017 and specialises in the early detection and diagnosis of epilepsy. The company has developed a highly innovative, portable video-EEG-ECG recording system that patients can take home with them, rather than being limited to hospital use. Dr Freestone was one of three co-founders of...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by the Honourable Jaala Pulford, Chair of MTPConnect, Vice Chancellor’s Fellow at the University of Melbourne, and former Minister of the Parliament of Victoria. Jaala is well known for her career in public service where she has held several significant portfolios, including Minister for Agriculture, Minister for Small Business and Minister for Innovation, Medical Research and the Digital Economy. In her role as M...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Associate Professor Fiona Brownfoot, specialist obstetrician at the Mercy Hospital for Women, clinician scientist at the University of Melbourne and Co-Founder of Kali Healthcare. Kali Healthcare is undergoing an exciting commericalisation journey and aims to transform pregnancy monitoring through the development of a wearable device that will allow expecting mothers to monitor foetal heartbeats at home. ...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Devinder Chauhan, a highly respected retinal ophthalmologist and Founding CEO of Macuject. Macuject is a digital health company that harnesses AI to provide imaging and data solutions for ophthalmologists to them make clinical decisions when treating age-related macular degeneration. Dr Chauhan founded Macuject in 2017 and is currently making the transition from clinician to entrepreneur as he and his team ai...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Professor Andrew Wilks and Dr Chris Burns. Professor Wilks and Dr Burns are two research leaders who were involved in the incredible breakthrough of the drug, Momelotinib, which has emerged as a treatment for myelofibrosis – a rare type of bone marrow cancer. In this episode you will hear about: The journey of momelotinib from bench top to a commercial productProfessor Wilks and Dr Burns' experience as entrepreneursWhere ...
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Professor Moira O'Bryan, Dean of the Faculty of Science at the University of Melbourne. Professor O'Bryan specialises in andrology and through her impressive research career, she has recently been given the prestigious role of a Dean at the Unversity of Melbourne which is ranked as the 14th best preforming university in the world per the QS rankings. In this episode you will hear about: Moira's journey to becoming Dean of...
In the latest episode of Med Tech Talks, we present a special keynote speech from Dr Andres Fouras, Founding CEO of 4DMedical, recorded at the Bionics Institute 2023 Innovation Lecture. Dr Andreas Fouras and his team have developed a unique respiratory imaging system, which aims to change the outcome for patients with lung disease. In 2012, Andreas founded 4DMedical to commercialise the technology, which is now an ASX listed company. In his keynote, Andreas illustrates his entrepren...
In the latest episode of Med Tech Talks, we present a special keynote speech from Kylie Walker, CEO of the Australian Academy of Technological Sciences and Engineering (ATSE), recorded at the Bionics Institute 2023 Innovation Lecture. As CEO of ATSE, Kylie specialises in connecting technologists, engineers and scientists with governments, business, media and society with skills built over many years in senior federal communication and advocacy roles in science, technology and health sectors...